Subscribe to Cancer Epic, Avera Ink Deal to Use Liquid Biopsy Platform in Clinical Studies
28 January 2016
Epic Sciences and Avera Medical announced today that they have signed a deal under which the healthcare network will use the company's circulating tumor cell (CTC)-detection and -analysis platform in upcoming clinical studies of precision cancer therapies.
Avera Medical Group and Epic Sciences collaborate on cancer precision medicine clinical trials
28 January 2016
Epic Sciences, Inc. and Avera Medical Group announced today a collaboration on feasibility studies to better understand the effectiveness of personalized cancer treatments as part of novel ovarian and breast cancer clinical trials.
Key Southeast Asia markets show strong potential punch in 2016
28 January 2016
Outside of the main markets in China, Japan and India in Asia are closely followed plays in Indonesia, Thailand, Malaysia and Vietnam with the last two among 12 nations that signed the Trans-Pacific Partnership (TPP) trade pact.
FDA finally speeds up approval for ovarian cancer drugs
28 January 2016
The article, published in The New York Times earlier this year, said that the death of Dr Richard Pazdur’s wife, Mary, who battled ovarian cancer for three years, finally forced the US Food and Drug Administration (FDA) to work faster at testing and approving new drugs.
Pharma calls for collective action to combat antimicrobial resistance
28 January 2016
The declaration outlines for the first time how industry and governments can work together to support sustained innovation to address the growing problem of AMR by which bacteria and microbes become resistant to regularly used drugs, making common yet life-threatening infections difficult or even impossible to treat.
Politics and Pricing Will Challenge Manufacturers in 2016
27 January 2016
The escalating attack on rising expenditures for prescription drugs and biologics is prompting more proposals from Congress and political candidates to strengthen oversight of biopharmaceutical development, manufacturing, and marketing.
Big Pharma consortium rolls out clinical trial investigator platform
27 January 2016
Big Pharma consortium TransCelerate BioPharma has released a portal through which research sites can interact with multiple clinical trial sponsors. The portal is intended to free clinical trial sites from the duplicated workload and administrative burdens associated with using a different portal for each of the sponsors with which they work.
2015: A banner year for personalized medicine
27 January 2016
2015 was a record year for personalized medicine approvals, according to a new analysis from the Personalized Medicine Coalition (PMC). This news confirms the growing role of personalized medicine as an approach to treatment that can improve outcomes for patients and also create important efficiencies in the health care system. Personalized medicine is an emerging field of medicine that uses diagnostic tools to identify specific biological markers to help assess which medical treatments and procedures will be best for each patient.
Top Boston Sci exec says more women are needed in device clinical trials
26 January 2016
Dr. Ken Stein, the chief medical officer of Boston Scientific's ($BSX) rhythm management division, said that industry and the healthcare system are not doing a good job of ensuring women are adequately treated with cardiology devices like pacemakers and implantable defibrillators.
Framing Biopharma Success in 2016
26 January 2016
In the past 20 years, biopharma companies enjoyed success as blockbuster drugs dominated the market, made adjustments as the patent cliff approached, and in some cases, abandoned existing R&D programs to seek alternate, more profitable routes. Counterfeit drugs and drug shortages disrupted the delivery of safe, effective therapies to patients. Oversized, inefficient research, development, and manufacturing engines were downsized, or transferred to outsourcing providers.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024
CRISPR technologies fuelling haematological innovations
17 April 2024
17 April 2024